title: A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
abstract: A depot drug delivery system, fibrin encapsulated liposome-in-chitosan matrix (FLCM), has been developed to deliver a water-soluble drug which is configured by a porous chitosan matrix containing a bovine fibrin network encapsulated different surface properties of liposomes. Quinacrine (QR), a water-soluble, low-molecular weight fluorescent marker, is used as a model drug to evaluate the delivery characteristics of the system. The SEM photographs show that the fibrin network adheres to the surfaces and pores of the chitosan matrix of a FLCM system. The QR release periods of the FLCM are sustained for about four times longer than those of QR encapsulated into the liposomes. However, the QR release periods and profiles of the FLCM are influenced by the surface properties of liposomes. The release of QR from FLCM is sustained for 9 days for neutral liposomes and only 5 days for PEG modified liposomes (PEG-liposome). After crosslinking the fibrin network of the FLCM with 0.5% of glutaldehyde, the release of QR is further sustained for 17 days with good linear profiles (e.g., 13 days) and with 50% of reduced burst release compared with those of without crosslinking, indicating that the stability of the fibrin network plays an important role on QR release of the system. More interestingly, the release periods and profiles of QR of the FLCM system are highly similar to those of Tirofiban, low-molecular weight of a water-soluble clinical cardiovascular drug, although the study has been done by human platelet poor plasma instead of bovine fibrinogen as a source of fibrin network. It suggests that the QR is a suitable model for investigating the drug delivery behaviors for water-soluble, low-molecular weight drugs of the FLCM. In conclusion, with QR as a model drug, FLCM with crosslinked fibrin network can effectively sustain the release of QR for 17 days but the release profiles are influenced by the surface properties of encapsulated liposomes. This study suggests that FLCM may have the potential as a depot drug delivery system for water-soluble drugs.
authors.affiliation: Department of Chemical Engineering, National Yunlin University of Science and Technology, Yunlin 640, Taiwan, ROC. twchung@yuntech.edu.tw
authors.forename: Tze-Wen
authors.initials: TW
authors.lastname: Chung
authors.forename: Min-Chia
authors.initials: MC
authors.lastname: Yang
authors.forename: Wei-Jean
authors.initials: WJ
authors.lastname: Tsai
mesh_terms: D000588:Amines / Q000737:chemistry; D048271:Chitosan / Q000737:chemistry*; D003432:Cross-Linking Reagents / Q000737:chemistry; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D005337:Fibrin / Q000737:chemistry*; D005976:Glutaral / Q000737:chemistry; D008081:Liposomes; D010755:Organophosphates / Q000737:chemistry; D010316:Particle Size; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry; D016062:Porosity; D011796:Quinacrine / Q000008:administration & dosage / Q000737:chemistry*; D012995:Solubility; D013499:Surface Properties; D013997:Time Factors; D000077466:Tirofiban; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D014867:Water / Q000737:chemistry
chemical_list: D000588:Amines; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D008081:Liposomes; D010755:Organophosphates; D010975:Platelet Aggregation Inhibitors; D014867:Water; C002290:dicetylphosphate; D011092:Polyethylene Glycols; D014443:Tyrosine; D005337:Fibrin; D048271:Chitosan; C009317:stearylamine; D000077466:Tirofiban; D011796:Quinacrine; D005976:Glutaral